Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome
Background--Intestinal microbiota have been found to be linked to cardiovascular disease via conversion of the dietary compounds choline and carnitine to the atherogenic metabolite TMAO (trimethylamine-N-oxide). Specifically, a vegan diet was associated with decreased plasma TMAO levels and nearly absent TMAO production on carnitine challenge. Methods and Results--We performed a double-blind randomized controlled pilot study in which 20 male metabolic syndrome patients were randomized to single lean vegan-donor or autologous fecal microbiota transplantation. At baseline and 2 weeks thereafter, we determined the ability to produce TMAO from d6-choline and d3-carnitine (eg, labeled and unlabeled TMAO in plasma and 24-hour urine after oral ingestion of 250 mg of both isotope-labeled precursor nutrients), and fecal samples were collected for analysis of microbiota composition. 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans of the abdominal aorta, as well as ex vivo peripheral blood mononuclear cell cytokine production assays, were performed. At baseline, fecal microbiota composition differed significantly between vegans and metabolic syndrome patients. With vegan-donor fecal microbiota transplantation, intestinal microbiota composition in metabolic syndrome patients, as monitored by global fecal microbial community structure, changed toward a vegan profile in some of the patients; however, no functional effects from vegan-donor fecal microbiota transplantation were seen on TMAO production, abdominal aortic 18Ffluorodeoxyglucose uptake, or ex vivo cytokine production from peripheral blood mononuclear cells. Conclusions--Single lean vegan-donor fecal microbiota transplantation in metabolic syndrome patients resulted in detectable changes in intestinal microbiota composition but failed to elicit changes in TMAO production capacity or parameters related to vascular inflammation.
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article/Letter to editor biblioteca |
Language: | English |
Subjects: | Atherosclerosis, Cardiovascular disease, Cardiovascular imaging, Inflammation, Metabolism, |
Online Access: | https://research.wur.nl/en/publications/effect-of-vegan-fecal-microbiota-transplantation-on-carnitine-and |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
dig-wur-nl-wurpubs-536429 |
---|---|
record_format |
koha |
spelling |
dig-wur-nl-wurpubs-5364292024-10-30 Smits, Loek P. Kootte, Ruud S. Levin, Evgeni Prodan, Andrei Fuentes, Susana Zoetendal, Erwin G. Wang, Zeneng Levison, Bruce S. Cleophas, Maartje C.P. Kemper, E.M. Dallinga-Thie, Geesje M. Groen, Albert K. Joosten, Leo A.B. Netea, Mihai G. Stroes, Erik S.G. de Vos, Willem M. Hazen, Stanley L. Nieuwdorp, Max Article/Letter to editor Journal of the American Heart Association 7 (2018) 7 ISSN: 2047-9980 Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome 2018 Background--Intestinal microbiota have been found to be linked to cardiovascular disease via conversion of the dietary compounds choline and carnitine to the atherogenic metabolite TMAO (trimethylamine-N-oxide). Specifically, a vegan diet was associated with decreased plasma TMAO levels and nearly absent TMAO production on carnitine challenge. Methods and Results--We performed a double-blind randomized controlled pilot study in which 20 male metabolic syndrome patients were randomized to single lean vegan-donor or autologous fecal microbiota transplantation. At baseline and 2 weeks thereafter, we determined the ability to produce TMAO from d6-choline and d3-carnitine (eg, labeled and unlabeled TMAO in plasma and 24-hour urine after oral ingestion of 250 mg of both isotope-labeled precursor nutrients), and fecal samples were collected for analysis of microbiota composition. 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans of the abdominal aorta, as well as ex vivo peripheral blood mononuclear cell cytokine production assays, were performed. At baseline, fecal microbiota composition differed significantly between vegans and metabolic syndrome patients. With vegan-donor fecal microbiota transplantation, intestinal microbiota composition in metabolic syndrome patients, as monitored by global fecal microbial community structure, changed toward a vegan profile in some of the patients; however, no functional effects from vegan-donor fecal microbiota transplantation were seen on TMAO production, abdominal aortic 18Ffluorodeoxyglucose uptake, or ex vivo cytokine production from peripheral blood mononuclear cells. Conclusions--Single lean vegan-donor fecal microbiota transplantation in metabolic syndrome patients resulted in detectable changes in intestinal microbiota composition but failed to elicit changes in TMAO production capacity or parameters related to vascular inflammation. en application/pdf https://research.wur.nl/en/publications/effect-of-vegan-fecal-microbiota-transplantation-on-carnitine-and 10.1161/JAHA.117.008342 https://edepot.wur.nl/446870 Atherosclerosis Cardiovascular disease Cardiovascular imaging Inflammation Metabolism https://creativecommons.org/licenses/by-nc-nd/4.0/ Wageningen University & Research |
institution |
WUR NL |
collection |
DSpace |
country |
Países bajos |
countrycode |
NL |
component |
Bibliográfico |
access |
En linea |
databasecode |
dig-wur-nl |
tag |
biblioteca |
region |
Europa del Oeste |
libraryname |
WUR Library Netherlands |
language |
English |
topic |
Atherosclerosis Cardiovascular disease Cardiovascular imaging Inflammation Metabolism Atherosclerosis Cardiovascular disease Cardiovascular imaging Inflammation Metabolism |
spellingShingle |
Atherosclerosis Cardiovascular disease Cardiovascular imaging Inflammation Metabolism Atherosclerosis Cardiovascular disease Cardiovascular imaging Inflammation Metabolism Smits, Loek P. Kootte, Ruud S. Levin, Evgeni Prodan, Andrei Fuentes, Susana Zoetendal, Erwin G. Wang, Zeneng Levison, Bruce S. Cleophas, Maartje C.P. Kemper, E.M. Dallinga-Thie, Geesje M. Groen, Albert K. Joosten, Leo A.B. Netea, Mihai G. Stroes, Erik S.G. de Vos, Willem M. Hazen, Stanley L. Nieuwdorp, Max Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome |
description |
Background--Intestinal microbiota have been found to be linked to cardiovascular disease via conversion of the dietary compounds choline and carnitine to the atherogenic metabolite TMAO (trimethylamine-N-oxide). Specifically, a vegan diet was associated with decreased plasma TMAO levels and nearly absent TMAO production on carnitine challenge. Methods and Results--We performed a double-blind randomized controlled pilot study in which 20 male metabolic syndrome patients were randomized to single lean vegan-donor or autologous fecal microbiota transplantation. At baseline and 2 weeks thereafter, we determined the ability to produce TMAO from d6-choline and d3-carnitine (eg, labeled and unlabeled TMAO in plasma and 24-hour urine after oral ingestion of 250 mg of both isotope-labeled precursor nutrients), and fecal samples were collected for analysis of microbiota composition. 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans of the abdominal aorta, as well as ex vivo peripheral blood mononuclear cell cytokine production assays, were performed. At baseline, fecal microbiota composition differed significantly between vegans and metabolic syndrome patients. With vegan-donor fecal microbiota transplantation, intestinal microbiota composition in metabolic syndrome patients, as monitored by global fecal microbial community structure, changed toward a vegan profile in some of the patients; however, no functional effects from vegan-donor fecal microbiota transplantation were seen on TMAO production, abdominal aortic 18Ffluorodeoxyglucose uptake, or ex vivo cytokine production from peripheral blood mononuclear cells. Conclusions--Single lean vegan-donor fecal microbiota transplantation in metabolic syndrome patients resulted in detectable changes in intestinal microbiota composition but failed to elicit changes in TMAO production capacity or parameters related to vascular inflammation. |
format |
Article/Letter to editor |
topic_facet |
Atherosclerosis Cardiovascular disease Cardiovascular imaging Inflammation Metabolism |
author |
Smits, Loek P. Kootte, Ruud S. Levin, Evgeni Prodan, Andrei Fuentes, Susana Zoetendal, Erwin G. Wang, Zeneng Levison, Bruce S. Cleophas, Maartje C.P. Kemper, E.M. Dallinga-Thie, Geesje M. Groen, Albert K. Joosten, Leo A.B. Netea, Mihai G. Stroes, Erik S.G. de Vos, Willem M. Hazen, Stanley L. Nieuwdorp, Max |
author_facet |
Smits, Loek P. Kootte, Ruud S. Levin, Evgeni Prodan, Andrei Fuentes, Susana Zoetendal, Erwin G. Wang, Zeneng Levison, Bruce S. Cleophas, Maartje C.P. Kemper, E.M. Dallinga-Thie, Geesje M. Groen, Albert K. Joosten, Leo A.B. Netea, Mihai G. Stroes, Erik S.G. de Vos, Willem M. Hazen, Stanley L. Nieuwdorp, Max |
author_sort |
Smits, Loek P. |
title |
Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome |
title_short |
Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome |
title_full |
Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome |
title_fullStr |
Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome |
title_full_unstemmed |
Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome |
title_sort |
effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-n-oxide production and vascular inflammation in patients with metabolic syndrome |
url |
https://research.wur.nl/en/publications/effect-of-vegan-fecal-microbiota-transplantation-on-carnitine-and |
work_keys_str_mv |
AT smitsloekp effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT kootteruuds effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT levinevgeni effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT prodanandrei effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT fuentessusana effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT zoetendalerwing effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT wangzeneng effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT levisonbruces effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT cleophasmaartjecp effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT kemperem effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT dallingathiegeesjem effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT groenalbertk effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT joostenleoab effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT neteamihaig effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT stroeseriksg effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT devoswillemm effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT hazenstanleyl effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome AT nieuwdorpmax effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome |
_version_ |
1816157199432417280 |